DNDN Related Company Press Releases
-
Dendreon Announces First Quarter 2013 Results
-
PROVENGE® (sipuleucel-T) Data Presented at An Annual Scientific Urology Meeting
-
Mentor Capital Cancer Immunotherapy Index Gains 28% During First Quarter of 2013
-
Dendreon to Host Conference Call on May 9 to Announce First Quarter Financial Results
Back to DNDN Stock Lookup
